747487
Last Update Posted: 2013-05-27
Recruiting has ended
All Genders accepted | 14 Years-65 Years |
85 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy
This study is meant to assess the effectiveness of idebenone on visual function measures in patients with Leber's Hereditary Optic Neuropathy over a 6 months period.
The study involves 6 clinic visits.
Eligibility
Relevant conditions:
Leber's Hereditary Optic Neuropathy
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov